PropertyValue
?:abstract
  • The necessity and impact of SARS-CoV2 on the world\'s health have led to developing and producing practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. Including SARS, MERS, influenza, and the SARS-CoV-2 provide a safe immune response. Here, we review the information and studies that have been done to help develop strategies and perspectives for producing a safe and ideal vaccine to prevent COVID-19 in normal people, especially at high-risk groups such as diabetes patients. This article is protected by copyright. All rights reserved.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1002/bab.2076
?:journal
  • Biotechnology_and_applied_biochemistry
?:license
  • unk
?:pmid
?:pmid
  • 33179788
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • A review of COVID-19 vaccines and major considerations for diabetic patients.
?:type
?:year
  • 2020-11-12

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/3nislr13>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/3nislr13>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all